Short Interest in PureTech Health plc (OTCMKTS:PTCHF) Drops By 60.3%

PureTech Health plc (OTCMKTS:PTCHF) was the target of a large drop in short interest in January. As of January 15th, there was short interest totalling 6,000 shares, a drop of 60.3% from the December 31st total of 15,100 shares. Based on an average daily volume of 3,300 shares, the days-to-cover ratio is currently 1.8 days.

PureTech Health Price Performance

Shares of PureTech Health stock remained flat at $1.66 on Wednesday. The business’s 50-day simple moving average is $1.96 and its 200-day simple moving average is $2.01. PureTech Health has a 1-year low of $1.66 and a 1-year high of $3.00.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.